Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,052
archived clinical trials in
Nephrology

Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
St. Louis, MO
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Clinical Research Facility
mi
from
Indiana, PA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Clinical Research Facility
mi
from
Indiana, PA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  2/3/2016
Research Site
mi
from
Rosario,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 2/3/2016
Research Site
mi
from
Rosario,
Click here to add this to my saved trials
Permeability Factor in Focal Segmental Glomerulosclerosis
Permeability Factor in Focal Segmental Glomerulosclerosis
Status: Enrolling
Updated:  2/8/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Permeability Factor in Focal Segmental Glomerulosclerosis
Permeability Factor in Focal Segmental Glomerulosclerosis
Status: Enrolling
Updated: 2/8/2016
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)
Status: Enrolling
Updated:  2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Renogram Study With Percutaneous Nephrolithotomy (PERC): Alterations in Renal Blood Flow as a Consequence of PERC
Alterations in Renal Blood Flow as a Consequence of Percutaneous Nephrolithotomy (PERC)
Status: Enrolling
Updated: 2/22/2016
IU Health Methodist Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Tulane University Hospital and Clinic Department of Internal Medicine
mi
from
New Orleans, LA
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Tulane University Hospital and Clinic Department of Internal Medicine
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Northwest Louisiana Nephrology Research
mi
from
Shreveport, LA
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Northwest Louisiana Nephrology Research
mi
from
Shreveport, LA
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Wayne State University Lupus Database Departments of Internal Medicine and Obstetrics & Gynecology Division of Rheumatology Wayne State University School of Medicine
mi
from
Detroit, MI
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Wayne State University Lupus Database Departments of Internal Medicine and Obstetrics & Gynecology Division of Rheumatology Wayne State University School of Medicine
mi
from
Detroit, MI
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Seligman Center for Advanced Therapeutics
mi
from
New York, NY
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Seligman Center for Advanced Therapeutics
mi
from
New York, NY
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Rheumatology Clinical Research Unit, Division of Rheumatology University Hospitals Case Medical Center
mi
from
Beachwood, OH
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Rheumatology Clinical Research Unit, Division of Rheumatology University Hospitals Case Medical Center
mi
from
Beachwood, OH
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
University of Cincinnati College of Medicine
mi
from
Cincinnati, OH
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Ohio State University Medical Center
mi
from
Columbus, OH
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Southwest Rheumatology and Research Group, LLC
mi
from
Middleburg Heights, OH
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Southwest Rheumatology and Research Group, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
1711 St. Julian Place
mi
from
Columbia, SC
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
1711 St. Julian Place
mi
from
Columbia, SC
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Acme Research L.L.C.
mi
from
Orangeburg, SC
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Acme Research L.L.C.
mi
from
Orangeburg, SC
Click here to add this to my saved trials
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated:  2/22/2016
Institute of Rheumatology
mi
from
Prague, 128 50,
The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atacicept in Subjects With Lupus Nephritis in Combination With Mycophenolate Mofetil Therapy.
Status: Enrolling
Updated: 2/22/2016
Institute of Rheumatology
mi
from
Prague, 128 50,
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Chattanooga, TN
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Los Angeles, CA
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Chicago, IL
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Lake Success, NY
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Columbus, OH
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Duncansville, PA
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Duncansville, PA
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Clinical Research Facility
mi
from
Carrollton, TX
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Clinical Research Facility
mi
from
Carrollton, TX
Click here to add this to my saved trials
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated:  2/25/2016
Investigational Site
mi
from
Brussels,
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate Efficacy and Safety of Treatment With CNTO 136 Administered Intravenously in Subjects With Active Lupus Nephritis
Status: Enrolling
Updated: 2/25/2016
Investigational Site
mi
from
Brussels,
Click here to add this to my saved trials
High Water Intake to Slow Progression of Polycystic Kidney Disease
The Effect of Water Loading on Urinary Biomarkers
Status: Enrolling
Updated:  3/7/2016
New York University Langone Medical Center
mi
from
New York, NY
High Water Intake to Slow Progression of Polycystic Kidney Disease
The Effect of Water Loading on Urinary Biomarkers
Status: Enrolling
Updated: 3/7/2016
New York University Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Sylmar, CA
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Sylmar, CA
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Clinical Research Facility
mi
from
Lima, OH
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Clinical Research Facility
mi
from
Lima, OH
Click here to add this to my saved trials
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated:  3/8/2016
Research Site
mi
from
Cordoba,
Ceftazidime-Avibactam Compared With Doripenem Followed by Oral Therapy for Hospitalized Adults With Complicated UTIs (Urinary Tract Infections)
A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults
Status: Enrolling
Updated: 3/8/2016
Research Site
mi
from
Cordoba,
Click here to add this to my saved trials
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
Status: Enrolling
Updated:  3/28/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
Use of Tolvaptan to Reduce Urinary Supersaturation: a Pilot Proof of Principle Study
Status: Enrolling
Updated: 3/28/2016
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated:  4/1/2016
Providence Medical Research Center
mi
from
Spokane, WA
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Status: Enrolling
Updated: 4/1/2016
Providence Medical Research Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research
Mobile Technologies Assisting Patients & Family Caregivers in Healthy Living
Status: Enrolling
Updated:  4/12/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Home Parenteral Nutrition (HPN) Families' Mobile Distance Connections to Care Research
Mobile Technologies Assisting Patients & Family Caregivers in Healthy Living
Status: Enrolling
Updated: 4/12/2016
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients
Calcineurin Inhibitors to Belatacept Switch Study to Prevent the Progression of Kidney Disease in Pancreas Transplant Alone Recipients
Status: Enrolling
Updated:  5/4/2016
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients
Calcineurin Inhibitors to Belatacept Switch Study to Prevent the Progression of Kidney Disease in Pancreas Transplant Alone Recipients
Status: Enrolling
Updated: 5/4/2016
Indiana University Health - University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Heart Care Research, LLC
mi
from
Huntsville, AL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Heart Care Research, LLC
mi
from
Huntsville, AL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
St. Luke's Medical Center
mi
from
Phoenix, AZ
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
St. Luke's Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Kaiser Permanente
mi
from
Los Angeles, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Kaiser Permanente
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Stanford Hospitals and Clinics
mi
from
Stanford, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Harbor-UCLA
mi
from
Torrance, CA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Harbor-UCLA
mi
from
Torrance, CA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
The Heart & Vascular Institute Of Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Infinity Clinical Research, LLC
mi
from
Hollywood, FL
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Saint Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Franciscan St. Francis Health, Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
St. Mary's Medical Center
mi
from
Duluth, MN
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
St. Mary's Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Elyria Memorial Hospital Medical Center
mi
from
Elyria, OH
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Elyria Memorial Hospital Medical Center
mi
from
Elyria, OH
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Oklahoma Foundation for Cardiovascular Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
South Carolina Heart Center
mi
from
Columbia, SC
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
South Carolina Heart Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated:  5/18/2016
Greenville Health System
mi
from
Greenville, SC
Contrast Media Reduction and Removal in Patients With CKD (PRESERV)
PRESERV (Prospective Randomized Evaluation to Study the Effects of Reduced Contrast Media on the Vitality of the Kidney) Pivotal Trial
Status: Enrolling
Updated: 5/18/2016
Greenville Health System
mi
from
Greenville, SC
Click here to add this to my saved trials